| pubmed-article:12605103 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12605103 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:12605103 | lifeskim:mentions | umls-concept:C1556094 | lld:lifeskim |
| pubmed-article:12605103 | lifeskim:mentions | umls-concept:C0058698 | lld:lifeskim |
| pubmed-article:12605103 | lifeskim:mentions | umls-concept:C0027849 | lld:lifeskim |
| pubmed-article:12605103 | lifeskim:mentions | umls-concept:C1335671 | lld:lifeskim |
| pubmed-article:12605103 | lifeskim:mentions | umls-concept:C0004083 | lld:lifeskim |
| pubmed-article:12605103 | lifeskim:mentions | umls-concept:C1882417 | lld:lifeskim |
| pubmed-article:12605103 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:12605103 | pubmed:dateCreated | 2003-2-26 | lld:pubmed |
| pubmed-article:12605103 | pubmed:abstractText | The molecular basis of neuroleptic malignant syndrome (NMS) is unclear, but clinical studies have noted a genetic predisposition. A recent genetic study suggested an association between NMS and the I A polymorphism in the dopamine D2 receptor (DRD2 ) gene. We further examined the association in a larger number of subjects. | lld:pubmed |
| pubmed-article:12605103 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12605103 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12605103 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12605103 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12605103 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12605103 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12605103 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12605103 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:12605103 | pubmed:issn | 0955-8829 | lld:pubmed |
| pubmed-article:12605103 | pubmed:author | pubmed-author:SuzukiKyokoK | lld:pubmed |
| pubmed-article:12605103 | pubmed:author | pubmed-author:KosakaKenjiK | lld:pubmed |
| pubmed-article:12605103 | pubmed:author | pubmed-author:FurunoTakuT | lld:pubmed |
| pubmed-article:12605103 | pubmed:author | pubmed-author:KishidaIkukoI | lld:pubmed |
| pubmed-article:12605103 | pubmed:author | pubmed-author:KawanishiChia... | lld:pubmed |
| pubmed-article:12605103 | pubmed:author | pubmed-author:MatsumuraTake... | lld:pubmed |
| pubmed-article:12605103 | pubmed:author | pubmed-author:HasegawaHanaH | lld:pubmed |
| pubmed-article:12605103 | pubmed:author | pubmed-author:SugiyamaNaoya... | lld:pubmed |
| pubmed-article:12605103 | pubmed:author | pubmed-author:YamadaYoshite... | lld:pubmed |
| pubmed-article:12605103 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12605103 | pubmed:volume | 13 | lld:pubmed |
| pubmed-article:12605103 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12605103 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12605103 | pubmed:pagination | 55-7 | lld:pubmed |
| pubmed-article:12605103 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:12605103 | pubmed:meshHeading | pubmed-meshheading:12605103... | lld:pubmed |
| pubmed-article:12605103 | pubmed:meshHeading | pubmed-meshheading:12605103... | lld:pubmed |
| pubmed-article:12605103 | pubmed:meshHeading | pubmed-meshheading:12605103... | lld:pubmed |
| pubmed-article:12605103 | pubmed:meshHeading | pubmed-meshheading:12605103... | lld:pubmed |
| pubmed-article:12605103 | pubmed:meshHeading | pubmed-meshheading:12605103... | lld:pubmed |
| pubmed-article:12605103 | pubmed:meshHeading | pubmed-meshheading:12605103... | lld:pubmed |
| pubmed-article:12605103 | pubmed:meshHeading | pubmed-meshheading:12605103... | lld:pubmed |
| pubmed-article:12605103 | pubmed:meshHeading | pubmed-meshheading:12605103... | lld:pubmed |
| pubmed-article:12605103 | pubmed:meshHeading | pubmed-meshheading:12605103... | lld:pubmed |
| pubmed-article:12605103 | pubmed:meshHeading | pubmed-meshheading:12605103... | lld:pubmed |
| pubmed-article:12605103 | pubmed:meshHeading | pubmed-meshheading:12605103... | lld:pubmed |
| pubmed-article:12605103 | pubmed:meshHeading | pubmed-meshheading:12605103... | lld:pubmed |
| pubmed-article:12605103 | pubmed:meshHeading | pubmed-meshheading:12605103... | lld:pubmed |
| pubmed-article:12605103 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12605103 | pubmed:articleTitle | Lack of association in Japanese patients between neuroleptic malignant syndrome and the TaqI A polymorphism of the dopamine D2 receptor gene. | lld:pubmed |
| pubmed-article:12605103 | pubmed:affiliation | Department of Psychiatry, Yokohama City University School of Medicine, Yokohama, Japan. | lld:pubmed |
| pubmed-article:12605103 | pubmed:publicationType | Journal Article | lld:pubmed |
| entrez-gene:1813 | entrezgene:pubmed | pubmed-article:12605103 | lld:entrezgene |
| entrez-gene:255239 | entrezgene:pubmed | pubmed-article:12605103 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:12605103 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:12605103 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:12605103 | lld:entrezgene |
| lhgdn:association:14823 | lhgdn:found_in | pubmed-article:12605103 | lld:lhgdn |
| lhgdn:association:36393 | lhgdn:found_in | pubmed-article:12605103 | lld:lhgdn |
